x
- Home
- Diabetes Models
- In Vivo Models of Diabetes Mellitus
- In Vitro Models of Diabetes Mellitus
- Diabetes Drug R&D Services
- Therapeutic Areas
- Virtual Booth
- Company
Cat. No.: DMM-001232
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | This model successfully generated Inppl1 knockout mice by deleting the fifth exon of the Inppl1 gene, which can be used to study diabetes and metabolic syndrome. |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | Inppl1 |
| Synonyms | 51C; SHIP2 |
| Gene ID | 16332 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
